News
11-11-2013, 05:20 AM
Nutranomics, Inc. is pleased to provide this update regarding the GenEpic prostate cancer human clinical study that is currently underway. Nutranomics has previously announced a non-binding Letter of Intent with Genesar Nutraceuticals, LLC with the intent of completing a licencing agreement to market and distribute GenEpic globally.
More... (http://www.news-medical.net/news/20131111/Nutranomics-provides-update-on-GenEpic-prostate-cancer-human-clinical-study.aspx)
More... (http://www.news-medical.net/news/20131111/Nutranomics-provides-update-on-GenEpic-prostate-cancer-human-clinical-study.aspx)